Vascular specialist response to Medicare Evidence Development Coverage Advisory Committee (MEDCAC) panel on peripheral artery disease of the lower extremities
Vasc Med
.
2016 Jun;21(3):281-6.
doi: 10.1177/1358863X16636955.
Epub 2016 Apr 10.
Authors
Mehdi H Shishehbor
1
,
Herbert D Aronow
2
,
John R Bartholomew
3
,
Joshua A Beckman
4
,
James B Froehlich
5
,
Robert Lookstein
6
,
Sanjay Misra
7
,
Anne C Roberts
8
,
Kenneth Rosenfield
9
,
Michael R Jaff
10
Affiliations
1
Cleveland Clinic, Cleveland, OH, USA (represented SCAI)
[email protected]
.
2
Brown University, Providence, RI, USA.
3
Cleveland Clinic, Cleveland, OH, USA (represented SVM).
4
Vanderbilt University, Nashville, TN, USA.
5
University of Michigan, Ann Arbor, MI, USA (represented SVM).
6
Mount Sinai, New York, NY, USA (represented SIR).
7
Mayo Clinic, Rochester, MN, USA (represented SIR).
8
University of California, San Diego, La Jolla, CA, USA (represented ACR).
9
Massachusetts General Hospital, Boston, MA, USA (represented SCAI).
10
Massachusetts General Hospital, Boston, MA, USA (represented VIVA).
PMID:
27063017
DOI:
10.1177/1358863X16636955
No abstract available
MeSH terms
Advisory Committees
Humans
Lower Extremity
Medicare*
Peripheral Arterial Disease / therapy*
United States